ArticleBMC cancer2024

Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies.

Angeliki Andrikopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.